New Hope in Fight Against COVID - 2 Vaccines
1st Pfizer/BioNTech COVID Vaccine, Now Moderna Vaccine
Source: Moderna COVID Vaccine
Moderna Vaccine is 94.5% Effective, Pfizer More than 90%
More hope in the fight against the COVID-19 global pandemic. Cambridge, MA based biotech Moderna reports that it has a COVID vaccine candidate that is 94.5% effective against the deadly virus . COVID-19 has infected more than 55 million people and taken more than 1.3 million lives globally as of today.
Pfizer/Germany's BioNTech Vaccine
Moderna has the second highly acclaimed vaccine candidate since Pfizer/BioNTech announced theirs a few days ago. Pfizer claims their vaccine has a more than 90% effective rate. These vaccines have to be approved by regulatory authorities, but their results look very promising and are giving global medical experts hope of quick turnaround deployments.
Dr. Anthony Fauci's Take
The US's top infectious disease expert Dr. Anthony Fauci says that he is optimistic about the vaccines. He thinks that COVID vaccines could start being used in the second half of December for high risk groups like health care workers, elderly and people with pre-existing conditions. For the rest of the population, the vaccines should be available in the spring of 2021.
Brand New Vaccine Approach
Moderna says no serious side effects have resulted from their vaccine. Some people have felt mild symptoms like body aches and headaches. Pfizer and Moderna are using a very similar technology approach to vaccinate people against COVID. It's called mRNA and it provides a genetic cocktail that sits atop the coronavirus and attacks it by activating the body's immune system. This is medical innovation at the cutting edge. No vaccine on the market now uses mRNA.